Hydroxy/Hydroperoxy/Epoxy/Oxo Eicosanoids
Hydroxy/Hydroperoxy/Epoxy/Oxo Eicosanoids(羟基/过氧/环氧/氧代二十烷酸)
Hydroxy/Hydroperoxy/Epoxy/Oxo Eicosanoids 相关产品(130)
- GC411275(S),15(S)-DiHETECAS: 82200-87-1纯度: >98.00%
A dihydroxy fatty acid synthesized by 15-LO from 5(S)-HETE
- GC411368(S),15(S)-DiHETECAS: 80234-65-7纯度: >98.00%
A dihydroxy fatty acid synthesized by 15-LO from 15(S)-HETE
- GC41318(±)17(18)-EpETE methyl esterCAS: 141339-46-0纯度: >98.00%
An esterified form of (±)17(18)-EpETE
- GC41651(±)14(15)-EET-SICAS: 218461-97-3纯度: >95.00%
A potent, metabolically stable analog of 14(15)-EpETrE
- GC41652(±)14(15)-EpEDECAS: 351533-80-7纯度: >98.00%
A monoepoxide derived from 8,11,14-eicosatrienoic acid
- GC4208420-hydroxy Arachidic Acid methyl esterCAS: 37477-29-5纯度: >98.00%
A hydroxy fatty acid methyl ester
- GC4208520-hydroxy N-Arachidonoyl Taurine纯度: >95.00%
A potential CYP450 metabolite of N-arachidonoyl-taurine
- GC421622-hydroxy Arachidic Acid methyl esterCAS: 16742-49-7纯度: >98.00%
A hydroxy fatty acid methyl ester
- GC424795(S)-HETrECAS: 195061-94-0纯度: >98.00%
A monohydroxy fatty acid synthesized by 5-LO from mead acid
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC41126 | 5(S),12(S)-DiHETE | 79056-01-2 | >98.00% | |
A natural bioactive lipid | ||||
| GC41127 | 5(S),15(S)-DiHETE | 82200-87-1 | >98.00% | |
A dihydroxy fatty acid synthesized by 15-LO from 5(S)-HETE | ||||
| GC41128 | 5(S),6(R)-11-trans DiHETE | 129263-59-8 | >95.00% | |
A metabolite of LTA 4 | ||||
| GC41136 | 8(S),15(S)-DiHETE | 80234-65-7 | >98.00% | |
A dihydroxy fatty acid synthesized by 15-LO from 15(S)-HETE | ||||
| GC41143 | (±)11,12-DiHETE | 867350-92-3 | >98.00% | |
An EPA metabolite | ||||
| GC41146 | FOG9 | - | >98.00% | |
A 1,6-adduct formed through conjugation of 5-oxoETE with glutathione | ||||
| GC41288 | (±)17(18)-EpETE-Ethanolamide | 2123491-23-4 | >98.00% | |
An ω-3 endocannabinoid epoxide | ||||
| GC41318 | (±)17(18)-EpETE methyl ester | 141339-46-0 | >98.00% | |
An esterified form of (±)17(18)-EpETE | ||||
| GC41319 | (±)5(6)-EpETE methyl ester | 127716-49-8 | >98.00% | |
A stable derivative of 5(6)-EpETE | ||||
| GC41322 | 5-OxoETE methyl ester | 74785-00-5 | >95.00% | |
An esterified form of 5-oxoETE | ||||
| GC41388 | 2-hydroxy Arachidic Acid | 16742-48-6 | >98.00% | |
A hydroxy fatty acid | ||||
| GC41403 | 15(S)-HpEDE | 145375-41-3 | >98.00% | |
A 15-LO product derived from eicosadienoic acid | ||||
| GC41650 | (±)14(15)-EET Ethanolamide | - | >95.00% | |
A potential cytochrome P450 metabolite of AEA | ||||
| GC41651 | (±)14(15)-EET-SI | 218461-97-3 | >95.00% | |
A potent, metabolically stable analog of 14(15)-EpETrE | ||||
| GC41652 | (±)14(15)-EpEDE | 351533-80-7 | >98.00% | |
A monoepoxide derived from 8,11,14-eicosatrienoic acid | ||||
| GC41662 | (±)5(6)-EET Ethanolamide | - | >95.00% | |
A potential cytochrome P450 metabolite of AEA | ||||
| GC41665 | (±)8(9)-EET Ethanolamide | - | >98.00% | |
A cytochrome P450 metabolite of AEA | ||||
| GC41882 | 12(S)-HETrE | 72710-10-2 | >98.00% | |
An inhibitor of platelet activation | ||||
| GC41940 | 15-OxoEDE | 105835-44-7 | >95.00% | |
A PUFA produced by oxidation of 15-HEDE | ||||
| GC42083 | 20-HETE Ethanolamide | 942069-11-6 | >98.00% | |
A putative CYP450 metabolite of AEA | ||||
| GC42084 | 20-hydroxy Arachidic Acid methyl ester | 37477-29-5 | >98.00% | |
A hydroxy fatty acid methyl ester | ||||
| GC42085 | 20-hydroxy N-Arachidonoyl Taurine | - | >95.00% | |
A potential CYP450 metabolite of N-arachidonoyl-taurine | ||||
| GC42162 | 2-hydroxy Arachidic Acid methyl ester | 16742-49-7 | >98.00% | |
A hydroxy fatty acid methyl ester | ||||
| GC42479 | 5(S)-HETrE | 195061-94-0 | >98.00% | |
A monohydroxy fatty acid synthesized by 5-LO from mead acid | ||||
